Cargando…

The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis

Low-density lipoprotein receptor–related protein-1 (LRP1) is a large endocytic and signaling receptor belonging to the LDL receptor (LDLR) gene family and that is widely expressed in several tissues. LRP1 comprises a large extracellular domain (ECD; 515 kDa, α chain) and a small intracellular domain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiefang, Su, Ying, Pi, Shulan, Hu, Bo, Mao, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192809/ https://www.ncbi.nlm.nih.gov/pubmed/34124208 http://dx.doi.org/10.3389/fcvm.2021.682389

Ejemplares similares

Corrigendum: The dual role of low-density lipoprotein receptor–related protein 1 in atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2023)

Low-Density Lipoprotein Receptor-Related Protein-1 Signaling in Angiogenesis
por: Mao, Hua, et al.
Publicado: (2017)

Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster
por: Lin, Xiao, et al.
Publicado: (2021)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Decreased low-density lipoprotein receptor-related protein 1 expression in pro-inflammatory monocytes is associated with subclinical atherosclerosis
por: Albertini, Ricardo A., et al.
Publicado: (2022)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2018)

Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing
por: Potere, Nicola, et al.
Publicado: (2019)

Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis
por: Hong, Christin G., et al.
Publicado: (2023)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019
por: Du, Heyue, et al.
Publicado: (2022)

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
por: Yao, Younan, et al.
Publicado: (2022)

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis
por: Seo, Jeong Hun, et al.
Publicado: (2023)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

High-Throughput Screening Identifies MicroRNAs Regulating Human PCSK9 and Hepatic Low-Density Lipoprotein Receptor Expression
por: van Solingen, Coen, et al.
Publicado: (2021)

Comparison of a Machine Learning Method and Various Equations for Estimating Low-Density Lipoprotein Cholesterol in Korean Populations
por: Kwon, Yu-Jin, et al.
Publicado: (2022)

U-Shaped Relationship of Low-Density Lipoprotein Cholesterol With Risk of Severe COVID-19 From a Multicenter Pooled Analysis
por: Gong, Jiao, et al.
Publicado: (2021)

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis
por: Abudukeremu, Ayiguli, et al.
Publicado: (2021)

Identification of amino acid residues in the MT-loop of MT1-MMP critical for its ability to cleave low-density lipoprotein receptor
por: Wang, Maggie, et al.
Publicado: (2022)

Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial
por: Yu, Qixiang, et al.
Publicado: (2023)

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population
por: Jiang, Ming, et al.
Publicado: (2022)

High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
por: Jomard, Anne, et al.
Publicado: (2020)

Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease
por: Wang, Shih-Wei, et al.
Publicado: (2022)

Association of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy
por: Tang, Xixiang, et al.
Publicado: (2021)

Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence
por: Uchikado, Yoshihiro, et al.
Publicado: (2021)

Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review
por: Ravnskov, Uffe, et al.
Publicado: (2016)

Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights
por: Lee, Hsiang-Chun, et al.
Publicado: (2022)

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction
por: Chen, Min, et al.
Publicado: (2023)

Association between low-density lipoprotein cholesterol level and mortality in patients with cardiogenic shock: a retrospective cohort study
por: Jin, Jiali, et al.
Publicado: (2021)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
por: Ward, Natalie C., et al.
Publicado: (2022)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

High-Density Lipoprotein – A Hero, a Mirage, or a Witness?
por: Sviridov, Dmitri
Publicado: (2014)

Role of NFAT in the Progression of Diabetic Atherosclerosis
por: Cai, Yaoyao, et al.
Publicado: (2021)

The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction
por: Yang, Yu, et al.
Publicado: (2023)

Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2021)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
por: Hafiane, Anouar, et al.
Publicado: (2022)

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study
por: Guan, Xu-Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hr2fulk929b0bseiqoufri3mdq